Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Q32 Bio Inc. (QTTB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Q32 Bio Inc. (QTTB), most recent 12 months reported: revenue $53.74M, net income $33.79M, free cash flow -$33.54M. Latest balance sheet on file: liquid cash $106.27M. From SEC filings. Others in Pharmaceutical Preparations: Nektar Therapeutics · PROTHENA CORPORATION PUBLIC LIMITED COMPANY · Aquestive Therapeutics, Inc. · Tango Therapeutics, Inc. · Siga Technologies INC · GOSSAMER BIO, INC. · OCULAR THERAPEUTIX, INC · Spero Therapeutics, Inc.

Stock screener

Watchlist